drugset / Trial / NCT01040325

Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study

NCT01040325 ↗

Phase 2 Completed 723 enrolled Intercell USA, Inc.
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy of the TD Vaccine System to prevent moderate to severe enterotoxin E.coli (ETEC) disease in travelers to India.

Timeline

Start
2009-12
Primary completion
2010-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator TD Vaccine System Vaccine — —

Indications